| Literature DB >> 22915279 |
Keiki Ogino1, Masayuki Kubo, Hidekazu Takahashi, Ran Zhang, Yu Zou, Yoshihisa Fujikura.
Abstract
The present study was aimed to investigate the effect of an arginase inhibitor, N-hydroxy-nor-L-arginine (nor-NOHA) and a corticosteroid, prednisolone, in an intranasal mite-induced NC/Nga mouse model of asthma. The treatment with nor-NOHA and prednisolone inhibited the increase in airway hyperresponsiveness, the number of bronchoalveolar lavage fluid cells, protein expression of arginase I and arginase II, messenger RNA (mRNA) expression of nitric oxide synthase (NOS)2 and Th2 cytokines such as interleukin (IL)-4, IL-5, and IL-13, and the pathological inflammatory changes of the lung. NOx levels in the lung were not changed in mice treated with prednisolone and elevated in mice treated with nor-NOHA or prednisolone plus nor-NOHA despite suppressed NOS2 mRNA expression. The study concluded that anti-inflammatory effect by nor-NOHA might be dependent on NO supply from depleted NO by downregulated arginine availability of arginase and was not related with the anti-inflammatory mechanisms by prednisolone.Entities:
Mesh:
Substances:
Year: 2013 PMID: 22915279 DOI: 10.1007/s10753-012-9529-3
Source DB: PubMed Journal: Inflammation ISSN: 0360-3997 Impact factor: 4.092